1.) Qin S, Liu K, Chen Y, Zhou Y, Zhao W, Yan R, Xin P, Zhu Y, Wang H, Lang N (2024 Sep 20). Prediction of pathological response and lymph node metastasis after neoadjuvant therapy in rectal cancer through tumor and mesorectal MRI radiomic features. Scientific reports, 14(1), 21927. . PMID: 39304726.
2.) Alvarez JA, Shi Q, Dasari A, Garcia-Aguilar J, Sanoff H, George TJ, Hong T, Yothers G, Philip P, Nelson G, Al Baghdadi T, Alese OB, Zambare W, Omer D, Verheij FS, Bercz A, Kim MJ, Buckley J, Williams H, George M, Garcia R, Gallagher P, O'Reilly EM, Meyerhardt JA, Crawley J, Shergill A, Horvat N, Romesser PB, Hall W, Smith JJ (2024 Jul 26). Alliance A022104/NRG-GI010: The Janus Rectal Cancer Trial: a randomized phase II/III trial testing the efficacy of triplet versus doublet chemotherapy regarding clinical complete response and disease-free survival in patients with locally advanced rectal cancer. BMC cancer, 24(1), 901. . PMID: 39060961.
3.) Wei Q, Chen L, Hou X, Lin Y, Xie R, Yu X, Zhang H, Wen Z, Wu Y, Liu X, Chen W (2024 Jun 26). Multiparametric MRI-based radiomic model for predicting lymph node metastasis after neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Insights into imaging, 15(1), 163. . PMID: 38922456.
4.) Chen H, Zhang JH, Hao Q, Wu XL, Guo JX, Huang CX, Zhang J, Xing GS, An ZL, Ling Y, Zhao JG, Bao YN (2024 Jun 26). Analysis of tumor microenvironment alterations in partially responsive rectal cancer patients treated with neoadjuvant chemoradiotherapy. International journal of colorectal disease, 39(1), 99. . PMID: 38926205.
5.) Turri G, Ostuzzi G, Vita G, Barresi V, Scarpa A, Milella M, Mazzarotto R, Ruzzenente A, Barbui C, Pedrazzani C (2024 Jun 3). Treatment of Locally Advanced Rectal Cancer in the Era of Total Neoadjuvant Therapy: A Systematic Review and Network Meta-Analysis. JAMA network open, 7(6), e2414702. . PMID: 38833249.
6.) Chen Z, Zou Z, Qian M, Xu Q, Xue G, Yang J, Luo T, Hu L, Wang B (2024 Jun). A retrospective cohort study of neoadjuvant chemoradiotherapy combined with immune checkpoint inhibitors in locally advanced rectal cancer. Translational oncology, 44(), 101955. . PMID: 38583351.
7.) Bande AD, Handiso TB, Hanjelo HW, Jena BH (2024 May 23). Early discontinuation of long-acting reversible contraceptives methods and its associated factors in Hosanna town, central Ethiopia: a cross-sectional study. Scientific reports, 14(1), 11841. . PMID: 38782935.
8.) Eristu T, Mekis A, Abdo RA (2024 May 10). Determinants of postpartum long-acting reversible contraceptives in the extended postpartum period in Shashago district, Central Ethiopia: a cross-sectional study conducted in the community. Contraception and reproductive medicine, 9(1), 21. . PMID: 38730446.
9.) de'Angelis N, Marchegiani F, Martínez-Pérez A, Biondi A, Pucciarelli S, Schena CA, Pellino G, Kraft M, van Lieshout AS, Morelli L, Valverde A, Lupinacci RM, Gómez-Abril SA, Persiani R, Tuynman JB, Espin-Basany E, Ris F (2024 May 8). Robotic, transanal, and laparoscopic total mesorectal excision for locally advanced mid/low rectal cancer: European multicentre, propensity score-matched study. BJS open, 8(3), . . PMID: 38805357.
10.) Pan Z, Wang Y, Li S, Cai H, Guan G (2024 May 2). The prognostic role of the change in albumin-derived neutrophil-to-lymphocyte ratio during neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer. Biomolecules & biomedicine, 24(3), 612-624. . PMID: 38041687.
11.) Li Y, Zhuang M, Hu G, Zhang J, Qiu W, Mei S, Tang J (2024 Apr 26). A novel classification of posterior pelvic exenteration to assess prognosis in female patients with locally advanced primary rectal cancer: a retrospective cohort study from China PelvEx collaborative. International journal of colorectal disease, 39(1), 59. . PMID: 38664256.
12.) Cai H, Lin Y, Wu Y, Wang Y, Li S, Zhang Y, Zhuang J, Liu X, Guan G (2024 Apr 15). The prognostic model and immune landscape based on cancer-associated fibroblast features for patients with locally advanced rectal cancer. Heliyon, 10(7), e28673. . PMID: 38590874.
13.) Zhou J, Huang J, Zhou Z, Deng X, Wu Q, Wang Z (2024 Mar 16). Total neoadjuvant therapy for locally advanced rectal cancer: a three-group propensity score matched study. International journal of colorectal disease, 39(1), 38. . PMID: 38492080.
14.) Alden SL, Lee V, Narang AK, Meyer J, Gearhart SL, Christenson ES (2024 Mar 4). Circulating Tumor DNA to Predict Radiographic and Pathologic Response to Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer. The oncologist, 29(3), e414-e418. . PMID: 38180954.
15.) Liu IC, Gearhart S, Ke S, Hu C, Chung H, Efron J, Gabre-Kidan A, Najjar P, Atallah C, Safar B, Christenson ES, Azad NS, Lee V, Zaheer A, Birkness-Gartman JE, Reddy AV, Narang AK, Meyer J (2024 Mar). Surgical and local control outcomes after sequential short-course radiation therapy and chemotherapy for rectal cancer. Surgery open science, 18(), 42-49. . PMID: 38318322.
16.) Mills R, Mangone ER, Lesh N, Jayal G, Mohan D, Baraitser P (2024 Feb 27). Chatbots That Deliver Contraceptive Support: Systematic Review. Journal of medical Internet research, 26(), e46758. . PMID: 38412028.
17.) Mottola M, Golfieri R, Bevilacqua A (2024 Feb 9). The Effectiveness of an Adaptive Method to Analyse the Transition between Tumour and Peritumour for Answering Two Clinical Questions in Cancer Imaging. Sensors (Basel, Switzerland), 24(4), . . PMID: 38400314.
18.) Zhang H, Li Y, Xia F, Sun Y, Shen L, Wan J, Chen Y, Wang Y, Zhou M, Wu R, Zhou S, Wang Y, Liu F, Cai S, Zhang Z (2024 Feb 2). Study protocol of short-course radiotherapy combined with CAPOX and PD-1 inhibitor for locally advanced colon cancer: a randomised, prospective, multicentre, phase II trial (TORCH-C). BMJ open, 14(2), e079442. . PMID: 38309748.
19.) Marjasuo S, Koskenvuo L, Lepistö A (2024 Jan 30). Findings in magnetic resonance imaging for restaging locally advanced rectal cancer. International journal of colorectal disease, 39(1), 23. . PMID: 38289485.
20.) Pathak N, Zhang CX, Boukari Y, Burns R, Menezes D, Hugenholtz G, French RS, Gonzalez-Izquierdo A, Mathur R, Denaxas S, Hayward A, Sonnenberg P, Aldridge RW (2024). Sexual and reproductive health and rights of migrant women attending primary care in England: A population-based cohort study of 1.2 million individuals of reproductive age (2009-2018). Journal of migration and health, 9(), 100214. . PMID: 38327760.
21.) Gervaso L, Ciardiello D, Gregato G, Guidi L, Valenza C, Ascione L, Boldrini L, Frassoni S, Cella CA, Spada F, Funicelli L, De Roberto G, Petz W, Borin S, Gerardi MA, Bottiglieri L, Tamayo D, Bertani E, Fumagalli Romario U, Bagnardi V, Curigliano G, Bertolini F, Fazio N, Zampino MG (2024). Circulating tumor DNA in patients with locally advanced rectal cancer treated with multimodal treatment. Therapeutic advances in medical oncology, 16(), 17588359241249602. . PMID: 38882445.
22.) Zhao Z, Yan M, Pang H, Chen L, Tang X, Chen Z, Chen X, Sun H (2024). Significance of Nutritional-Inflammatory Index as Predictors for Total Neoadjuvant Therapy-Induced Tumor Regression in Locally Advanced Rectal Cancer Patients. Journal of inflammation research, 17(), 3865-3878. . PMID: 38895140.
23.) Huang W, Feng Z, Ma M, Song F, Zeng S, Shao F, Yu X, Rong P, Chen J (2024). Different impacts of adipose tissue dynamics on prognosis in patients with resectable locally advanced rectal cancer treated with and without neoadjuvant treatment. Frontiers in oncology, 14(), 1421651. . PMID: 39148902.
24.) Chang L, Zhang X, He L, Ma Q, Fang T, Jiang C, Ma Z, Li Q, Wu C, Tao J (2023 Dec 11). Prognostic Value of ctDNA Detection in Patients With Locally Advanced Rectal Cancer Undergoing Neoadjuvant Chemoradiotherapy: A Systematic Review and Meta-analysis. The oncologist, 28(12), e1198-e1208. . PMID: 37294663.
25.) Zhou H, Wang L, Lin Z, Jiang C, Chen X, Wang K, Liu L, Shao L, Pan J, Li J, Zhang D, Wu J (2023 Nov 30). Methylglyoxal from gut microbes boosts radiosensitivity and radioimmunotherapy in rectal cancer by triggering endoplasmic reticulum stress and cGAS-STING activation. Journal for immunotherapy of cancer, 11(11), . . PMID: 38035726.
26.) Guan B, Xu M, Zheng R, Guan G, Xu B (2023 Nov 12). Novel biomarkers to predict treatment response and prognosis in locally advanced rectal cancer undergoing neoadjuvant chemoradiotherapy. BMC cancer, 23(1), 1099. . PMID: 37953237.
27.) Solbakken AM, Sellevold S, Spasojevic M, Julsrud L, Emblemsvåg HL, Reims HM, Sørensen O, Thorgersen EB, Fauske L, Ågren JSM, Brennhovd B, Ryder T, Larsen SG, Flatmark K (2023 Nov). Navigation-Assisted Surgery for Locally Advanced Primary and Recurrent Rectal Cancer. Annals of surgical oncology, 30(12), 7602-7611. . PMID: 37481493.
28.) Zhou X, Yu Y, Feng Y, Ding G, Liu P, Liu L, Ren W, Zhu Y, Cao W (2023 Oct 27). Attention mechanism based multi-sequence MRI fusion improves prediction of response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Radiation oncology (London, England), 18(1), 175. . PMID: 37891611.
29.) Li C, Chen H, Zhang B, Fang Y, Sun W, Wu D, Su Z, Shen L, Wei Q (2023 Oct 25). Radiomics Signature Based on Support Vector Machines for the Prediction of Pathological Complete Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer. Cancers, 15(21), . . PMID: 37958309.
30.) Shimada A, Matsuda T, Sawada R, Hasegawa H, Yamashita K, Harada H, Urakawa N, Goto H, Kanaji S, Oshikiri T, Kakeji Y (2023 Oct 10). The modified Glasgow prognostic score is a reliable predictor of oncological outcomes in patients with rectal cancer undergoing neoadjuvant chemoradiotherapy. Scientific reports, 13(1), 17111. . PMID: 37816855.
31.) Darney BG, Biel FM, Oakley J, Coleman-Minahan K, Cottrell EK (2023 Sep 1). Contraceptive Method Switching and Long-Acting Reversible Contraception Removal in U.S. Safety Net Clinics, 2016-2021. Obstetrics and gynecology, 142(3), 669-678. . PMID: 37535965.
32.) Mi J, Wang R, Han X, Ma R, Zhao D (2023 Sep). Treatment stratification and prognosis assessment using circulating tumor DNA in locally advanced rectal cancer: A systematic review and meta-analysis. Cancer medicine, 12(17), 17934-17944. . PMID: 37553845.
33.) van Rees JM, Krul MF, Kok NFM, Grünhagen DJ, Kok END, Nierop PMH, Havenga K, Rutten H, Burger JWA, de Wilt JHW, Hagendoorn J, Peters FP, Buijsen J, Tanis PJ, Verhoef C, Kuhlmann KFD (2023 Aug 11). Treatment of locally advanced rectal cancer and synchronous liver metastases: multicentre comparison of two treatment strategies. The British journal of surgery, 110(9), 1049-1052. . PMID: 36821778.
34.) Mills R, Mangone ER, Lesh N, Mohan D, Baraitser P (2023 Aug 9). Chatbots to Improve Sexual and Reproductive Health: Realist Synthesis. Journal of medical Internet research, 25(), e46761. . PMID: 37556194.
35.) Luo D, Yang Y, Zhang R, Li Q, Li X (2023 Jul 1). Effect of interval between neoadjuvant chemoradiotherapy and surgery on oncological outcomes in poor responders with locally advanced rectal cancer: a retrospective cohort study. International journal of surgery (London, England), 109(7), 1993-2000. . PMID: 37184445.
36.) Lee TH, Jang BS, Chang JH, Kim E, Park JH, Chie EK (2023 Jul). Genomic landscape of locally advanced rectal adenocarcinoma: Comparison between before and after neoadjuvant chemoradiation and effects of genetic biomarkers on clinical outcomes and tumor response. Cancer medicine, 12(14), 15664-15675. . PMID: 37260182.
37.) Johansson L, Vesström J, Alehagen S, Kilander H (2023 Jun 29). Women's experiences of dealing with fertility and side effects in contraceptive decision making: a qualitative study based on women's blog posts. Reproductive health, 20(1), 98. . PMID: 37381022.
38.) Wang G, Yao K, Yang Y, Chen H, Tang Z, Ye J, Fu M, Xue X, Shen Q, Tang H, Guo Y, Huang Y (2023 Jun 13). Local resection versus radical resection after neoadjuvant chemoradiotherapy for patients with locally advanced rectal cancer: a propensity-score matched cohort analysis. BMC gastroenterology, 23(1), 205. . PMID: 37312044.
39.) Han YM, Qi WX, Wang SB, Cao WG, Chen JY, Cai G (2023 Jun). Identification of patients with locally advanced rectal cancer eligible for neoadjuvant chemotherapy alone: Results of a retrospective study. Cancer medicine, 12(12), 13309-13318. . PMID: 37148548.
40.) Liu S, Wang X, Zhuang Y, Bai S, Wu X, Ye Y, Luo H, Yu H, Wang Q, Chang H, Zeng Z, Cai P, Pan Z, Gao Y, Chen G, Xiao W (2023 Jun). Total neoadjuvant treatment to increase the clinical complete response rate for distal locally advanced rectal cancer (TESS): A study protocol of a prospective, open-label, multicenter, single-arm, phase 2 trial. Cancer medicine, 12(12), 13352-13360. . PMID: 37156624.
41.) Manoochehry S, Rasouli HR, Ahmadpour F, Keramati A (2023 Jun). Evaluation of the role of inflammatory blood markers in predicting the pathological response after neoadjuvant chemoradiation in patients with locally advanced rectal cancer. Radiation oncology journal, 41(2), 81-88. . PMID: 37403350.
42.) Lee S, Kang DH, Ahn TS, Jo DH, Kim E, Baek MJ (2023 Jun). Clinical influence of neoadjuvant chemoradiotherapy on immunonutritional status in locally advanced rectal cancer. Korean journal of clinical oncology, 19(1), 3-10. . PMID: 37449393.
43.) Kefeni BT, Tesfaye S, Bayisa K, Negara E, Bati F (2023 May 4). Determinants of long act reversible contraceptive utilization among HIV positive reproductive age women attending ART clinic in South West Ethiopia. Contraception and reproductive medicine, 8(1), 30. . PMID: 37143084.
44.) Wurschi GW, Güllmar D, Gaßler N, Clement J, Kesselmeier M, Müller-Wurschi JJ, Settmacher U, Mothes H, Helfritzsch H, Liebe Y, Franiel T, Mäurer MA, Ernst T, Nicolay NH, Wittig A (2023 Apr 25). Planning adaptive treatment by longitudinal response assessment implementing MR imaging, liquid biopsy and analysis of microenvironment during neoadjuvant treatment of rectal cancer (PRIMO). Medicine, 102(17), e33575. . PMID: 37115093.
45.) Gielen AHC, Colier E, Qiu SS, Keymeulen KBMI, Stassen LPS, Melenhorst J (2023 Apr 24). Research highlight: surgical outcomes of gluteal VY plasty after extensive abdominoperineal resection or total pelvic exenteration. Langenbeck's archives of surgery, 408(1), 157. . PMID: 37088846.
46.) Grinshpun A, Kustanovich A, Neiman D, Lehmann-Werman R, Zick A, Meir K, Vainer E, Granit RZ, Arad A, Daskal N, Schwartz R, Sapir E, Maoz M, Tahover E, Moss J, Ben-Dov IZ, Peretz T, Hubert A, Shemer R, Dor Y (2023 Apr 1). A universal cell-free DNA approach for response prediction to preoperative chemoradiation in rectal cancer. International journal of cancer, 152(7), 1444-1451. . PMID: 36468189.
47.) Çelik H, Barlık F, Sökmen S, Terzi C, Canda AE, Sağol Ö, Sarıoğlu S, Ünlü M, Bilkay Görken İ, Arıcan Alıcıkuş Z, Öztop İ (2023 Mar 29). Diagnostic performance of magnetic resonance imaging in preoperative local staging of rectal cancer after neoadjuvant chemoradiotherapy. Diagnostic and interventional radiology (Ankara, Turkey), 29(2), 219-227. . PMID: 36971272.
48.) Mazza D, Shankar M, Botfield JR, Moulton JE, Chakraborty SP, Black K, Tomnay J, Bateson D, Church J, Laba TL, Kasza J, Norman WV (2023 Mar 22). Improving rural and regional access to long-acting reversible contraception and medical abortion through nurse-led models of care, task-sharing and telehealth (ORIENT): a protocol for a stepped-wedge pragmatic cluster-randomised controlled trial in Australian general practice. BMJ open, 13(3), e065137. . PMID: 36948556.
49.) Jin L, Yin A, Zhang X, Jiang H, Zhou L, Zhou X, Wang X, Qian X (2023 Mar 21). Integrating contraceptive services into existing perinatal care: protocol for a community-based cluster randomised controlled trial in Shanghai, China. BMJ open, 13(3), e066146. . PMID: 36944458.
50.) Zhang Z, Yi X, Pei Q, Fu Y, Li B, Liu H, Han Z, Chen C, Pang P, Lin H, Gong G, Yin H, Zai H, Chen BT (2023 Feb). CT radiomics identifying non-responders to neoadjuvant chemoradiotherapy among patients with locally advanced rectal cancer. Cancer medicine, 12(3), 2463-2473. . PMID: 35912919.
51.) Calvo Manuel FÁ, Serrano J, Solé C, Cambeiro M, Palma J, Aristu J, Garcia-Sabrido JL, Cuesta MA, Del Valle E, Lapuente F, Miñana B, Morcillo MÁ, Asencio JM, Pascau J (2023 Feb). Clinical feasibility of combining intraoperative electron radiation therapy with minimally invasive surgery: a potential for electron-FLASH clinical development. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 25(2), 429-439. . PMID: 36169803.
52.) Tian W, Yang Y, Qin Q, Zhang L, Wang Z, Su L, Zeng L, Chen H, Hu L, Hong J, Huang Y, Zhang Q, Zhao H (2023 Feb). Vimentin and tumor-stroma ratio for neoadjuvant chemoradiotherapy response prediction in locally advanced rectal cancer. Cancer science, 114(2), 619-629. . PMID: 36221784.
53.) Laohawiriyakamol S, Chaochankit W, Wanichsuwan W, Kanjanapradit K, Laohawiriyakamol T (2023 Feb). An investigation into tumor regression grade as a parameter for locally advanced rectal cancer and 5-year overall survival rate. Annals of coloproctology, 39(1), 59-70. . PMID: 36891632.
54.) Boydell V, Smith RD (2023). Hidden in plain sight: A systematic review of coercion and Long-Acting Reversible Contraceptive methods (LARC). PLOS global public health, 3(8), e0002131. . PMID: 37594941.
55.) Kamanga A, Lyazi M, Prust ML, Medina-Jaudes N, Ngosa L, Nalwabwe M, Ndhlovu M, Kaluba D, Mwiche A, Mugahi R, Batusa J, Zulu M, Musoke A, Shakwele H, Glover C, Aldrich E (2023). Strengthening systems to provide long-acting reversible contraceptives (LARCs) in public sector health facilities in Uganda and Zambia: Program results and learnings. PloS one, 18(8), e0290115. . PMID: 37594954.
56.) Zhong W, Wang Q, Shen X, Lv Y, Sun L, An R, Zhu H, Cai H, Chen G, Liu A, Du J (2023). Neutrophil Extracellular Trap is Surrogate Biomarker for Prognosis and Response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer. Journal of inflammation research, 16(), 6443-6455. . PMID: 38164163.
57.) Hu J, Sheng Y, Ma J, Tang Y, Liu D, Zhang J, Wei X, Yang Y, Liu Y, Zhang Y, Wang G (2023). Construction and validation of a progression prediction model for locally advanced rectal cancer patients received neoadjuvant chemoradiotherapy followed by total mesorectal excision based on machine learning. Frontiers in oncology, 13(), 1231508. . PMID: 38328435.
58.) Li X, Fang C, Wang X, Yu Y, Wang Z, Qiu M (2022 Dec). Neoadjuvant treatment of sintilimab plus hypofractionated radiotherapy for MSI-H/dMMR rectal cancer: A prospective, multicenter, phase Ib study. Cancer medicine, 11(23), 4405-4410. . PMID: 35352512.
59.) Moulton JE, Mazza D, Tomnay J, Bateson D, Norman WV, Black KI, Subasinghe AK (2022 Dec). Co-design of a nurse-led model of care to increase access to medical abortion and contraception in rural and regional general practice: A protocol. The Australian journal of rural health, 30(6), 876-883. . PMID: 36264024.
60.) Downey MMB, Patteson Poehling C, O'Connell S (2022 Dec). Measurement and Operationalization of the Social Determinants of Health and Long-Acting Reversible Contraception Use in the U.S.: A Systematic Scoping Review. AJPM focus, 1(2), 100032. . PMID: 37791245.
61.) Mihretie GS, Abebe SM, Abebaw Y, Gedefa L, Gure T, Alemayehu BA, Amenu D, Tadesse D, Fanta GA, Abubeker FA, Yemane A, G/Michael AD, Teklu AM, Damtew MH, Girma B (2022 Aug 2). Factors associated with discontinuation among long-acting reversible contraceptive users: a multisite prospective cohort study in urban public health facilities in Ethiopia. BMJ open, 12(8), e059372. . PMID: 35918115.
62.) Sully EA, Shiferaw S, Seme A, Bell SO, Giorgio M (2022 Jun). Impact of the Trump Administration's Expanded Global Gag Rule Policy on Family Planning Service Provision in Ethiopia. Studies in family planning, 53(2), 339-359. . PMID: 35639923.
63.) Chen L, Liu X, Zhang W, Qin S, Wang Y, Lin J, Chen Q, Liu G (2022 Jun). The predictive value of tumor volume reduction ratio on three-dimensional endorectal ultrasound for tumor response to chemoradiotherapy for locally advanced rectal cancer. Annals of translational medicine, 10(12), 666. . PMID: 35845508.
64.) Liu W, Li Y, Tang Y, Song Q, Wang J, Li N, Chen S, Shi J, Wang S, Li Y, Jiao Y, Zeng Y, Jin J (2022 Apr). Response prediction and risk stratification of patients with rectal cancer after neoadjuvant therapy through an analysis of circulating tumour DNA. EBioMedicine, 78(), 103945. . PMID: 35306340.
65.) Akiyoshi T, Shinozaki E, Taguchi S, Chino A, Hiratsuka M, Tominaga T, Nonaka T, Toda S, Matoba S, Matsui S, Okabayashi K, Mukai T, Hiyoshi Y, Yamaguchi T, Nagasaki T, Yamaguchi K, Ueno M, Kuroyanagi H, Fukunaga Y, Ishizuka N, Konishi T (2022 Mar 18). Non-operative management after chemoradiotherapy plus consolidation or sandwich (induction with bevacizumab and consolidation) chemotherapy in patients with locally advanced rectal cancer: a multicentre, randomised phase II trial (NOMINATE trial). BMJ open, 12(3), e055140. . PMID: 35304396.
66.) Tang B, Lenkowicz J, Peng Q, Boldrini L, Hou Q, Dinapoli N, Valentini V, Diao P, Yin G, Orlandini LC (2022 Mar 14). Local tuning of radiomics-based model for predicting pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. BMC medical imaging, 22(1), 44. . PMID: 35287607.
67.) Boniface ER, Rodriguez MI, Heintzman J, Knipper SH, Jacobs R, Darney BG (2022 Feb). A comparison of contraceptive services for adolescents at school-based versus community health centers in Oregon. Health services research, 57(1), 145-151. . PMID: 34624140.
68.) Chiloiro G, Cusumano D, Boldrini L, Romano A, Placidi L, Nardini M, Meldolesi E, Barbaro B, Coco C, Crucitti A, Persiani R, Petruzziello L, Ricci R, Salvatore L, Sofo L, Alfieri S, Manfredi R, Valentini V, Gambacorta MA (2022 Jan 15). THUNDER 2: THeragnostic Utilities for Neoplastic DisEases of the Rectum by MRI guided radiotherapy. BMC cancer, 22(1), 67. . PMID: 35033008.
69.) Li H, Yuan Y, Chen XL, Chen GW, Liu H, Liu YS, Pang MH, Liu SY, Pu H, Li ZL (2022 Jan). Value of intravoxel incoherent motion for assessment of lymph node status and tumor response after chemoradiation therapy in locally advanced rectal cancer. European journal of radiology, 146(), 110106. doi: 10.1016/j.ejrad.2021.110106. PMID: 34922118.
70.) Lin Z, Cai M, Zhang P, Li G, Liu T, Li X, Cai K, Nie X, Wang J, Liu J, Liu H, Zhang W, Gao J, Wu C, Wang L, Fan J, Zhang L, Wang Z, Hou Z, Ma C, Yang K, Wu G, Tao K, Zhang T (2021 Nov). Phase II, single-arm trial of preoperative short-course radiotherapy followed by chemotherapy and camrelizumab in locally advanced rectal cancer. Journal for immunotherapy of cancer, 9(11), . . PMID: 34725214.
71.) Kim JK, Marco MR, Choi SH, Qu X, Chen CT, Elkabets M, Fairchild L, Chow O, Barriga FM, Dow LE, O'Rourke K, Szeglin B, Yarilin D, Fujisawa S, Manova-Todorova K, Paty PB, Shia J, Leslie C, Smith JJ, Lowe S, Pelossof R, Sanchez-Vega F, Garcia-Aguilar J (2021 Oct). KRAS mutant rectal cancer cells interact with surrounding fibroblasts to deplete the extracellular matrix. Molecular oncology, 15(10), 2766-2781. . PMID: 33817986.
72.) Huang CM, Huang MY, Tsai HL, Huang CW, Su WC, Chang TK, Chen YC, Li CC, Wang JY (2021 Sep 13). Pretreatment Neutrophil-to-Lymphocyte Ratio Associated with Tumor Recurrence and Survival in Patients Achieving a Pathological Complete Response Following Neoadjuvant Chemoradiotherapy for Rectal Cancer. Cancers, 13(18), . . PMID: 34572816.
73.) van Rees JM, Visser E, van Vugt JLA, Rothbarth J, Verhoef C, van Verschuer VMT (2021 Sep 6). Impact of nutritional status and body composition on postoperative outcomes after pelvic exenteration for locally advanced and locally recurrent rectal cancer. BJS open, 5(5), . . PMID: 34672343.
74.) Koëter T, Stijns RCH, van Koeverden S, Hugen N, van der Heijden JAG, Nederend J, van Zwam PH, Nagtegaal ID, Verheij M, Rutten HJT, de Wilt JHW (2021 Sep). Poor response at restaging MRI and high incomplete resection rates of locally advanced mucinous rectal cancer after chemoradiation therapy. Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland, 23(9), 2341-2347. . PMID: 34051043.
75.) Zhang S, Zhang R, Li RZ, Wang QX, Chang H, Ding PR, Li LR, Wu XJ, Chen G, Zeng ZF, Xiao WW, Gao YH (2021 Sep). Beneficiaries of radical surgery among clinical complete responders to neoadjuvant chemoradiotherapy in rectal cancer. Cancer science, 112(9), 3607-3615. . PMID: 34146368.
76.) De Kort L, Wood J, Wouters E, Van de Velde S (2021 Aug 4). Abortion care in a pandemic: an analysis of the number and social profile of people requesting and receiving abortion care during the first COVID-19 lockdown (March 16 to June 14, 2020) in Flanders, Belgium. Archives of public health = Archives belges de sante publique, 79(1), 140. . PMID: 34344468.
77.) Wilson WC, Faburay B, Trujillo JD, Ragan I, Sunwoo SY, Morozov I, Shivanna V, Balogh A, Urbaniak K, McVey DS, Bold D, Gaudreault NN, Schirtzinger EE, Ma W, Richt JA (2021 Jul 6). Preliminary Evaluation of a Recombinant Rift Valley Fever Virus Glycoprotein Subunit Vaccine Providing Full Protection against Heterologous Virulent Challenge in Cattle. Vaccines, 9(7), . . PMID: 34358166.
78.) Liang Y, Zhu Y, Lin H, Zhang S, Li S, Huang Y, Liu C, Qu J, Liang C, Zhao K, Li Z, Liu Z (2021 Jun 25). The value of the tumour-stroma ratio for predicting neoadjuvant chemoradiotherapy response in locally advanced rectal cancer: a case control study. BMC cancer, 21(1), 729. . PMID: 34172021.
79.) Torky R, Alessa M, Kim HS, Sakr A, Zakarneh E, Sauri F, Bae H, Kim NK (2021 Jun). Characteristics of Patients Presented With Metastases During or After Completion of Chemoradiation Therapy for Locally Advanced Rectal Cancer: A Case Series. Annals of coloproctology, 37(3), 186-191. . PMID: 32972094.
80.) Lin H, Wang L, Zhong X, Zhang X, Shao L, Wu J (2021 May 5). Meta-analysis of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced rectal cancer. World journal of surgical oncology, 19(1), 141. . PMID: 33952287.
81.) Chiloiro G, Meldolesi E, Giraffa M, Capocchiano ND, Barbaro B, Coco C, Corvari B, De Franco P, D'Ugo D, Alfieri S, Manfredi R, Valentini V, Gambacorta MA (2021 May). Could the conservative approach be considered safe in the treatment of locally advanced rectal cancer in case of a clinical near-complete or complete response? A retrospective analysis. Clinical and translational radiation oncology, 28(), 1-9. . PMID: 33732909.
82.) Coppola F, Mottola M, Lo Monaco S, Cattabriga A, Cocozza MA, Yuan JC, De Benedittis C, Cuicchi D, Guido A, Rojas Llimpe FL, D'Errico A, Ardizzoni A, Poggioli G, Strigari L, Morganti AG, Bazzoli F, Ricciardiello L, Golfieri R, Bevilacqua A (2021 Apr 28). The Heterogeneity of Skewness in T2W-Based Radiomics Predicts the Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer. Diagnostics (Basel, Switzerland), 11(5), . . PMID: 33924854.
83.) Lu S, Liu Z, Wang B, Li F, Meng Y, Wang J, Wang Y, Wang H, Zhou X, Fu W (2021 Apr 13). High CFP score indicates poor prognosis and chemoradiotherapy response in LARC patients. Cancer cell international, 21(1), 205. . PMID: 33849545.
84.) Seo I, Lee HW, Byun SJ, Park JY, Min H, Lee SH, Lee JS, Kim S, Bae SU (2021 Mar). Neoadjuvant chemoradiation alters biomarkers of anticancer immunotherapy responses in locally advanced rectal cancer. Journal for immunotherapy of cancer, 9(3), . . PMID: 33692216.
85.) Li Z, Ma X, Shen F, Lu H, Xia Y, Lu J (2021 Feb 16). Evaluating treatment response to neoadjuvant chemoradiotherapy in rectal cancer using various MRI-based radiomics models. BMC medical imaging, 21(1), 30. . PMID: 33593304.
86.) Li Y, Liu D, Zhao L, Güngör C, Song X, Wang D, Liu W, Tan F (2021 Feb). Accurate nomograms with excellent clinical value for locally advanced rectal cancer. Annals of translational medicine, 9(4), 296. . PMID: 33708923.
87.) Shao K, Zheng R, Li A, Li X, Xu B (2021 Jan 13). Clinical predictors of pathological good response in locally advanced rectal cancer. Radiation oncology (London, England), 16(1), 10. . PMID: 33436026.
88.) Ngendahimana D, Amalraj J, Wilkinson B, Verbus E, Montague M, Morris J, Arora KS (2021 Jan 7). Association of race and ethnicity with postpartum contraceptive method choice, receipt, and subsequent pregnancy. BMC women's health, 21(1), 17. . PMID: 33413298.
89.) Zhai Z, Zhang K, Wang C, Zhang T, Wang L, Yao J, Wang Z (2021 Jan 6). Adding Three Cycles of CAPOX after Neoadjuvant Chemoradiotherapy Increases the Rates of Complete Response for Locally Advanced Rectal Cancer. Current oncology (Toronto, Ont.), 28(1), 283-293. . PMID: 33419188.
90.) Wang Y, Chen L, Zhang B, Song W, Zhou G, Xie L, Yu D (2021). Pretreatment Inflammatory-Nutritional Biomarkers Predict Responses to Neoadjuvant Chemoradiotherapy and Survival in Locally Advanced Rectal Cancer. Frontiers in oncology, 11(), 639909. . PMID: 33816284.
91.) Liu Y, Zhang FJ, Zhao XX, Yang Y, Liang CY, Feng LL, Wan XB, Ding Y, Zhang YW (2021). Development of a Joint Prediction Model Based on Both the Radiomics and Clinical Factors for Predicting the Tumor Response to Neoadjuvant Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer. Cancer management and research, 13(), 3235-3246. . PMID: 33880066.
92.) Suwantika AA, Zakiyah N, Puspitasari IM, Abdulah R (2021). Cost-Effectiveness of Contraceptive Use in Indonesia after the Implementation of the National Health Insurance System. Journal of pregnancy, 2021(), 3453291. . PMID: 34046230.
93.) Zhang Y, Gao Q, Wu Y, Peng Y, Zhuang J, Yang Y, Jiang W, Liu X, Guan G (2021). Hypermethylation and Downregulation of UTP6 Are Associated With Stemness Properties, Chemoradiotherapy Resistance, and Prognosis in Rectal Cancer: A Co-expression Network Analysis. Frontiers in cell and developmental biology, 9(), 607782. . PMID: 34485268.
94.) Yang Y, Tian W, Su L, Li P, Gong X, Shi L, Zhang Q, Zhao B, Zhao H (2021). Tumor-Infiltrating Cytotoxic T Cells and Tumor-Associated Macrophages Correlate With the Outcomes of Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer. Frontiers in oncology, 11(), 743540. . PMID: 34733785.
95.) Xu Y, Lou X, Liang Y, Zhang S, Yang S, Chen Q, Xu Z, Zhao M, Li Z, Zhao K, Liu Z (2021). Predicting Neoadjuvant Chemoradiotherapy Response in Locally Advanced Rectal Cancer Using Tumor-Infiltrating Lymphocytes Density. Journal of inflammation research, 14(), 5891-5899. . PMID: 34785927.
96.) Weldekidan HA, Lemlem SB, Sinishaw Abebe W, Sori SA (2022 Jan-Dec). Discontinuation rate of long-acting reversible contraceptives and associated factors among reproductive-age women in Butajira town, Central Ethiopia. Women's health (London, England), 18(), 17455057221104656. . PMID: 35726769.
97.) Mare KU, Abrha E, Mohammed Yesuf E, Birara Aychiluhm S, Tadesse AW, Leyto SM, Sabo KG, Mulaw GF, Mohammed OA, Ebrahim OA (2022 Jan-Dec). Factors affecting utilization of long-acting reversible contraceptives among sexually active reproductive-age women in the pastoral community of Northeast Ethiopia: A community-based cross-sectional study. Women's health (London, England), 18(), 17455057221116514. . PMID: 35946956.
98.) Ouyang G, Chen Z, Dou M, Luo X, Wen H, Deng X, Meng W, Yu Y, Wu B, Jiang D, Wang Z, Yao Y, Wang X (2023 Jan-Dec). Predicting Rectal Cancer Response to Total Neoadjuvant Treatment Using an Artificial Intelligence Model Based on Magnetic Resonance Imaging and Clinical Data. Technology in cancer research & treatment, 22(), 15330338231186467. . PMID: 37431270.
99.) Tsai HL, Yeh YS, Chen PJ, Chang YT, Chen YC, Su WC, Chang TK, Huang CW, Wang JY (2023 Jan-Dec). The Auxiliary Effects of Low-Molecular-Weight Fucoidan in Locally Advanced Rectal Cancer Patients Receiving Neoadjuvant Concurrent Chemoradiotherapy Before Surgery: A Double-Blind, Randomized, Placebo-Controlled Study. Integrative cancer therapies, 22(), 15347354231187153. . PMID: 37822243.
100.) Rega D, Granata V, Romano C, Fusco R, Aversano A, Ravo V, Petrillo A, Pecori B, Di Girolamo E, Tatangelo F, Avallone A, Delrio P (2024 Jan-Dec). Total mesorectal excision after rectal-sparing approach in locally advanced rectal cancer patients after neoadjuvant treatment: a high volume center experience. Therapeutic advances in gastrointestinal endoscopy, 17(), 26317745241231098. . PMID: 39044726.
